Answers are grounded in this paper and cite their sources.
Case series demonstrates safe endoscopic resection of early esophageal cancer overlying varices in cirrhotic patients, highlighting a viable staged treatment approach.
Patients with liver cirrhosis (LC) have a higher incidence rate of upper gastrointestinal cancer, including esophageal cancer (EC) [1]. As the seventh most deadly cancer globally and the third in China [2, 3], EC is one of the key threats to human health. Esophageal squamous cell carcinoma (ESCC) is the most common histological type of EC [4]. Clinically significant portal hypertension, especially accompanied with the presence of esophageal varices (EVs) on endoscopy, has a high risk of hemorrhage [5]. In this situation, endoscopic operations are difficult to avoid bleeding. Endoscopic submucosal dissection (ESD) is recommended as the preferred treatment for most superficial ESCC [6] and has shown excellent long-term outcomes [7, 8]. However, when ESCC coexists with EVs, management strategies become more complex due to the elevated bleeding risk. Here, we report two cases of ESCC accompanied with EVs caused by LC, which were successfully treated with ESD preceded by esophageal varix ligation (EVL) and hemostatic clip application. Case 1: A male patient aged 75 years was admitted to the Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for “alcoholic cirrhosis diagnosed 2 years ago and melena found 2 weeks ago” in December 2022. He had consumed 500 mL of Chinese liquor daily for over 50 years. Preoperative laboratory tests showed the following results: total bilirubin at 27.7 µmol/L, albumin at 32.8 g/L, prothrombin time of 14.9 s, and platelet count at 79 × 10⁹/L. No hepatic encephalopathy was observed, and moderate ascites was detected on ultrasound. The Child-Pugh classification was grade A. EVs (Location, Diameter, Risk factor [LDRf] classification: Le mi D1.0 Rf1) and early EC (a Paris IIb lesion of approximately 2.0 cm) on the EVs were found in the first gastroscopy (Figure S1A), and endoscopic injection sclerotherapy (EIS) combined with tissue adhesive injection (TAI) were performed. ESD was performed in February 2023. Multiple EVs were observed, located 20 cm from the incisors to the cardia. A 2.0 cm type IIb lesion with clear margins was identified on the left anterior wall at 25 cm from the incision under narrow-band imaging (NBI) (Figure 1A, Video S1). Intraepithelial papillary capillary loop (IPCL) expansion and a type B2 (Japan Esophageal Society classification) vessel area were noted. The lesion was located over one varix and close to another anteriorly and posteriorly. Endoscopic ultrasound (EUS) revealed a submucosal echoless area and hypoechoic mucosa (Figure S1B). Lugol's iodine (2.5%) staining demonstrated a pink-color sign (Figure S1C). The procedure began with EVL was performed approximately 5 cm distal to the tumor, starting from the cardia (Figure S1D). A hemostatic clip was applied, followed by lesion marking 2–3 mm beyond its margin using Argon plasma coagulation (APC). Lugol's iodine (2.5%) staining demonstrated a pink-color sign. Submucosal injection of glycerol-fructose methylene blue solution resulted in a positive lift sign. A single-use electrosurgical knife (EK-425D, Anrei Medical, Hangzhou, China) was used to perform incisions at the proximal, posterior, anterior, and distal edges, followed by submucosal dissection (Figure S1E). Minor bleeding was controlled with gentle electrocoagulation (Figure 1B). The lesion was then completely resected (Figure 1C). Hemostatic clips were applied to the resection area to prevent delayed perforation. Postoperatively, the patient remained Child-Pugh classification of grade A. Somatostatin was administered to prevent bleeding, and rabeprazole was prescribed. However, carvedilol was withheld due to bradycardia. The patient was discharged on postoperative day 7 without complications. Pathology confirmed high differentiated ESCC invading the muscularis mucosae (M3, according to the Japanese Classification of Esophageal Cancer), showing an intermediate infiltrative growth pattern (INFb) with negative mucosal and basal margins (Figure 1D). No recurrence or adverse event were observed during the follow-up gastroscopy in August 2023, with stable varices over 2 years requiring no further EVL. This case illustrates that a tailored, stepwise approach combining EIS, TAI, and targeted EVL before ESD can effectively manage early ESCC with overlying varices and achieve favorable long-term outcomes. Case 2: A male patient aged 61 years was admitted to Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine for “Hepatocellular carcinoma (HCC) diagnosed 3 years ago and coughing for 1 month” in December 2023. He was diagnosed with LC caused by the infection of hepatitis B virus 5 years ago and had been regularly taking tenofovir. He underwent HCC resection in 2022 and had been undergoing immunotherapy with tislelizumab. Preoperative laboratory tests showed the following results: total bilirubin at 51.4 µmol/L, albumin at 30 g/L, prothrombin time of 14.2 s, and platelet count at 127 × 10⁹/L. No hepatic encephalopathy was noted, and the ultrasound revealed moderate ascites. Taken together, the Child-Pugh classification was B. Early ESCC was diagnosed during examination (Figure 1E). EVLs of three adjacent varices were performed, followed by ESD 1 month later. After mucosal incision at the distal end of the lesion, varices were electro-coagulated and transected using forceps, with no obvious bleeding observed (Figure 1F, Figure S1F, Video S2). Circumferential incision and submucosal dissection were subsequently completed, and the lesion was resected without obvious damage to the muscle layer (Figure 1G). Postoperatively, the patient remained Child-Pugh classification of grade B and was discharged on day 7 without any adverse events. Carvedilol was prescribed. Pathology confirmed ESCC invading the muscularis mucosae (stage M3) (Figure 1H). This case illustrates that a proactive, staged approach involving sequential EVL followed by ESD can effectively manage early ESCC in the setting of extensive EVs and ensure procedural safety. ESCC shares common risk factors with LC, such as ethanol and smoking [9]. Both EC and EVs are associated with extreme alcohol consumption [10]. Thus, early ESCC may be identified during a follow-up endoscopy intended to evaluate the EVs of LC patients, particularly those with decompensated alcoholic cirrhosis. ESCC patients with Child-Pugh class A LC had significant rates of postoperative morbidity and mortality [9]. Thus, therapeutic decisions involving LC patients with ESCC are crucial. The management of EVs in LC patients seeking ESCC treatment by ESD must be carefully planned in advance. In some cases, EVL can cause retraction of the surrounding mucosa, leading to overlap between scar tissue and the tumor, thereby complicating subsequent ESD [11]. Another study showed that, in appropriate indications, EIS might improve liver function in patients with LC and result in a better prognosis than EVL [12]. While similar cases combining EVL and ESD have been reported previously, the novelty of our report lies in providing a practical, stepwise approach to individualized endoscopic management strategies. In Case 1, EIS and TAI were performed during the initial endoscopy to prevent potential bleeding from EVs. ESD was subsequently performed during a second endoscopy, following EVL, with only minimal controllable bleeding observed. The presence of EVs beneath the ESCC posed a technical challenge for ESD. A staged approach was adopted in our cases. EVs can be managed with EVL from the distal esophagus upward to obstruct the distal-to-proximal variceal blood flow. One month later, the procedure is initiated by incising the distal mucosa to expose the varix, which is subsequently coagulated before performing ESD. In summary, ESD can be a viable treatment option for early ESCC patients located at EVs caused by LC. Close monitoring and expertise at controlling bleeding are essential to managing varices during the procedure. Further studies and long-term follow-up are needed to validate its safety and efficacy. Zhuo Yu, Yueqiu Gao, and Jinzhong Yu conceived and designed the study. Biao Gong, Jia Shi, Shihan Yu, and Wurong Du acquired the data. Kun Liu, Fu Li, Xiaona Lu, and Xuemei Zhang interpreted the data. Wenlan Zheng drafted the manuscript. Zhuo Yu, Jinzhong Yu, and Hai Feng revised the manuscript for important intellectual content. All authors have contributed significantly. All authors have read and approved the final manuscript. This study was supported by National Natural Science Foundation of China (No. 82222074, and No. 82074154), Shuguang Program of Shanghai Education Development Foundation and Shanghai Municipal Education Commission (No. 23SG38), High-Level Key Discipline of the State Administration of Traditional Chinese Medicine (No. ZYYZDXK-2023060). The study was performed following the ethical standards of the institution and in line with the principles outlined in the Declaration of Helsinki. These cases were reviewed by the Institutional Review Board of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine and were deemed exempt from ethical approval. Written informed consents were obtained from the patients for the publication of these cases and the accompanying images. The authors declare no conflicts of interest. The authors confirm that the data supporting the findings of this study are available within the article and its supporting materials. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: